Stockreport
Cellectis: Calyxt Announces Proposed Initial Public Offering of $100.0 Million
Last cellectis sa american deposi earnings: 5/9 04:31 pm
Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors
PDF
ST. PAUL, Minn. & NEW YORK--(BUSINESS WIRE)-- Regulatory News: This Smart News Release features multimedia. View the full release here:http://www.businesswire.com/news/home/20170710005639/en/ Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) and Calyxt, Inc. announced today that Calyxt has commenced a proposed initial public offering of 6,060,606 shares of Calyxt’s common stock pursuant to a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). In connection with the offering, Calyxt intends to grant the underwriters an option to purchase up to 909,091 additional shares of common stock to cover over-allotments. The estimated price range for the initial public offering is $15.00 to $18.00 per share of common stock, which would result in gross proceeds of $100.0 million at the midpoint of the estimated price range. Calyxt has applied to list its common stock on the NASDAQ under the ticke
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | CLLS | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
CLLS alerts
CLLS alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLLS alerts
High impacting CELLECTIS SA AMERICAN DEPOSI news events
Weekly update
A roundup of the hottest topics
CLLS
NEWS
NEWS
- Rawadi named CEO of LNC Therapeutics [Reuters][Reuters]
- Cellectis to Present Data at the 2018 AACR Annual Meeting[Business Wire]
- Cellectis Announces Closing of Follow-On Offering[Business Wire]
- Is Cellectis SA Stock a Buy Now? [The Motley Fool][The Motley Fool]
- Cellectis: Monthly Information on Share Capital and Company Voting Rights[Business Wire]
- More
CLLS
SEC Filings
SEC Filings
- 4/13/18 - Form S-8
- 4/11/18 - Form 6-K
- 4/10/18 - Form 6-K
- CLLS's page on the SEC website
- More